A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation
- 15 June 2006
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 105 (2) , 150-158
- https://doi.org/10.1016/j.imlet.2006.02.002
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Structural and Functional Heterogeneity in the CD200R Family of Immunoregulatory Molecules and their Expression at the Feto‐maternal InterfaceAmerican Journal of Reproductive Immunology, 2004
- IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologyCytokine & Growth Factor Reviews, 2004
- Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic FracturesJournal of Bone and Mineral Research, 2002
- CpG oligonucleotides: novel regulators of osteoclast differentiationThe FASEB Journal, 2002
- CD200 Immunoadhesin Suppresses Collagen-Induced Arthritis in MiceClinical Immunology, 2001
- Minireview: The OPG/RANKL/RANK SystemEndocrinology, 2001
- Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiationBone, 2001
- Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-Endocrinology, 2000
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998